TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 6889432

Group type: EXPERIMENTAL
Intervention: Soy protein diet
Number of subjects: 12

Group type: COMPARATOR
Intervention: Animal protein diet
Number of subjects: 12
Study: 30559151

Group type: EXPERIMENTAL
Intervention: Sleep deprivation
Number of subjects: 32
Study: 28969711

Group type: EXPERIMENTAL
Intervention: Fatty fish meals three times per week for 12 weeks
Number of subjects: 426

Group type: COMPARATOR
Intervention: Meat meals
Number of subjects: 426

Group type: COMPARATOR
Intervention: n‐3 LCPUFA supplements
Number of subjects: 426
Study: 25260247

Group type: COMPARATOR
Intervention: Continuous exercise (CE, 30‐min cycling)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Accumulated exercise with 20 min of interval (AE20, 2 × 15‐min cycling)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Accumulated exercise with 60 min of interval (AE60, 2 × 15‐min cycling)
Number of subjects: 16
Study: 24519631

Group type: EXPERIMENTAL
Intervention: 0.1% bupivacaine with 15 μg·mL(‐1) hydromorphone (LA group)
Number of subjects: 39

Group type: COMPARATOR
Intervention: 0.9% saline (NS group)
Number of subjects: 39
Study: 22278302

Group type: EXPERIMENTAL
Intervention: Automated e-mail-based alert system
Number of subjects: 121

Group type: COMPARATOR
Intervention: Control group (no automated alerts)
Number of subjects: 121

Group type: EXPERIMENTAL
Intervention: Inpatient physician awareness
Number of subjects: 121

Group type: EXPERIMENTAL
Intervention: Impact on clinical assessments and plans
Number of subjects: 121

Group type: EXPERIMENTAL
Intervention: Urgency of results
Number of subjects: 121

Group type: EXPERIMENTAL
Intervention: Preferred alerting scenarios
Number of subjects: 121
Study: 19254939

Group type: EXPERIMENTAL
Intervention: Healthy lifestyle program intervention
Number of subjects: 460

Group type: COMPARATOR
Intervention: Control group (not explicitly defined in the abstract)
Number of subjects: 460
Study: 17914545

Group type: EXPERIMENTAL
Intervention: Clinutren HPR (whole protein of high protein value)
Number of subjects: 38

Group type: EXPERIMENTAL
Intervention: Crucial (casein peptide based formula)
Number of subjects: 38

Group type: EXPERIMENTAL
Intervention: Peptamen (whey peptide based formula)
Number of subjects: 38

Group type: EXPERIMENTAL
Intervention: Glytrol (formula for diabetics with whole protein with fiber)
Number of subjects: 38

Group type: COMPARATOR
Intervention: Standard meal (bread)
Number of subjects: 38
Study: 15284305

Group type: EXPERIMENTAL
Intervention: Digoxin therapy
Number of subjects: 6800

Group type: COMPARATOR
Intervention: Control (no digoxin therapy)
Number of subjects: 6800
Study: 11448320

Group type: EXPERIMENTAL
Intervention: OCT thickness at the 5‐o'clock inferior temporal position
Number of subjects: 91

Group type: EXPERIMENTAL
Intervention: HRT mean height contour in the nasal inferior region
Number of subjects: 91

Group type: EXPERIMENTAL
Intervention: GDx linear discriminant function
Number of subjects: 91

Group type: EXPERIMENTAL
Intervention: Qualitative assessment of stereophotographs
Number of subjects: 91

Group type: EXPERIMENTAL
Intervention: HRT parameters
Number of subjects: 91

Group type: EXPERIMENTAL
Intervention: GDx parameters
Number of subjects: 91

Group type: EXPERIMENTAL
Intervention: OCT parameters
Number of subjects: 91
Study: 9212121

Group type: EXPERIMENTAL
Intervention: Midazolam 0.5 mg/kg
Number of subjects: 24

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 24
Study: 8427134

Group type: EXPERIMENTAL
Intervention: Biphasic shocks
Number of subjects: 12

Group type: COMPARATOR
Intervention: Sequential pulse shocks
Number of subjects: 12
Study: 3676051

Group type: EXPERIMENTAL
Intervention: Single breath induction technique with isoflurane in nitrous oxide and oxygen
Number of subjects: 36

Group type: COMPARATOR
Intervention: Conventional inhalation induction technique with isoflurane in nitrous oxide and oxygen
Number of subjects: 36
Study: 30299491

Group type: EXPERIMENTAL
Intervention: 13-valent pneumococcal conjugate vaccine (PCV13)
Number of subjects: 663
Study: 28669167

Group type: EXPERIMENTAL
Intervention: AXL1717
Number of subjects: 0

Group type: COMPARATOR
Intervention: Docetaxel
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Leukocytosis (WBC > 9 x 10^9/L)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Normal WBC (WBC ≤ 9 x 10^9/L)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Anemia (Hgb < 110 g/L)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Normal Hgb (Hgb ≥ 110 g/L)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Thrombocytosis (Plt > 350 x 10^9/L)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Leukocytosis in multivariate model
Number of subjects: 0
Study: 25837356

Group type: COMPARATOR
Intervention: Tamsulosin (group B)
Number of subjects: 138

Group type: COMPARATOR
Intervention: Removing Stasis and Reducing Heat Formula (group C)
Number of subjects: 138

Group type: COMPARATOR
Intervention: Control group (group A)
Number of subjects: 138
Study: 24334483

Group type: EXPERIMENTAL
Intervention: Whole-body vibration (WBV) with balance exercise
Number of subjects: 55

Group type: COMPARATOR
Intervention: Balance exercise (BE)
Number of subjects: 55

Group type: COMPARATOR
Intervention: Control group (no training)
Number of subjects: 55
Study: 20169458

Group type: EXPERIMENTAL
Intervention: Experimental solution (SnCl(2) with 1,900 ppm Sn(2+) and 1,000 ppm F(-), pH 4.5)
Number of subjects: 8

Group type: COMPARATOR
Intervention: Positive control (SnF(2) mouth rinse with 409 ppm Sn(2+) and 250 ppm F(-), pH 4.2)
Number of subjects: 8

Group type: COMPARATOR
Intervention: Placebo (negative control)
Number of subjects: 8
Study: 19930833

Group type: EXPERIMENTAL
Intervention: Embolization of the draining veins with absolute ethanol followed by bleomycin A5 hydrochloride intra-tumoural injection
Number of subjects: 204

Group type: COMPARATOR
Intervention: Intra-tumoural injection only
Number of subjects: 204
Study: 16767966

Group type: EXPERIMENTAL
Intervention: 10 mg dexamethasone intravenously before induction of anesthesia
Number of subjects: 700

Group type: COMPARATOR
Intervention: Placebo (0.9% normal saline 2 ml)
Number of subjects: 700
Study: 15564114

Group type: EXPERIMENTAL
Intervention: Healthy subjects (normal sleep stages)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Sleep apnea
Number of subjects: 12
Study: 10938584

Group type: EXPERIMENTAL
Intervention: Trier Social Stress Test (TSST)
Number of subjects: 27
Study: 9052476

Group type: EXPERIMENTAL
Intervention: Immediate treatment (orchidectomy or luteinizing hormone-releasing hormone analogue)
Number of subjects: 938

Group type: COMPARATOR
Intervention: Deferred treatment
Number of subjects: 938
Study: 8336880

Group type: EXPERIMENTAL
Intervention: Extra-amniotic saline infusion plus intracervical Foley catheter balloon
Number of subjects: 112

Group type: COMPARATOR
Intervention: Prostaglandin E2 vaginal gel (2.85 mg)
Number of subjects: 112
Study: 3096164

Group type: EXPERIMENTAL
Intervention: Alfentanil bolus injection (n = 15) over 3 s
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Alfentanil slow injection (n = 15) over 30 s
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Succinylcholine (25 mg i.v.)
Number of subjects: 30
Study: 3384470

Group type: EXPERIMENTAL
Intervention: Clinic systolic pressure in hypertensive subjects
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: Clinic systolic pressure in normotensive subjects
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: Ambulatory and home pressures
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: Clinic diastolic pressures
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: Test-retest correlations of the three methods
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: Test-retest correlations of ambulatory standard deviations
Number of subjects: 27
Study: 31375283

Group type: EXPERIMENTAL
Intervention: Meatal stenosis (Group A)
Number of subjects: 206

Group type: COMPARATOR
Intervention: Control group (Group B)
Number of subjects: 206
Study: 31276809

Group type: EXPERIMENTAL
Intervention: High-dose Fentanyl Sublingual Spray (FSS) (35%-45% of total daily opioid dose)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Low-dose Fentanyl Sublingual Spray (FSS) (15%-25% of total daily opioid dose)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: High-dose Fentanyl Sublingual Spray (FSS)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 50
Study: 29911789

Group type: EXPERIMENTAL
Intervention: GlideScope®
Number of subjects: 46

Group type: COMPARATOR
Intervention: McIntosh laryngoscope
Number of subjects: 46
Study: 27164764

Group type: EXPERIMENTAL
Intervention: Resistance band exercises 5 times a week for 8 weeks
Number of subjects: 44

Group type: COMPARATOR
Intervention: Control group (no specific intervention mentioned)
Number of subjects: 44
Study: 23184506

Group type: EXPERIMENTAL
Intervention: Adaptive dual n-back training
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Nonadaptive training
Number of subjects: 0

Group type: COMPARATOR
Intervention: No-contact control group
Number of subjects: 0
Study: 21813882

Group type: EXPERIMENTAL
Intervention: Autologous fat transplantation (Group A; 12-165 mL per session)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Adipose-derived stem cell-enriched lipografts (Group B; 8-155 mL per session)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Comparison at 18 months
Number of subjects: 20
Study: 19288047

Group type: EXPERIMENTAL
Intervention: Clopidogrel
Number of subjects: 1869

Group type: COMPARATOR
Intervention: Ticlopidine
Number of subjects: 1869
Study: 16735482

Group type: EXPERIMENTAL
Intervention: Whey protein preload (50 g, 1.1 MJ, 450 ml)
Number of subjects: 72

Group type: EXPERIMENTAL
Intervention: Soy protein preload (50 g, 1.1 MJ, 450 ml)
Number of subjects: 72

Group type: EXPERIMENTAL
Intervention: Gluten protein preload (50 g, 1.1 MJ, 450 ml)
Number of subjects: 72

Group type: COMPARATOR
Intervention: Glucose treatment
Number of subjects: 72

Group type: EXPERIMENTAL
Intervention: All protein preloads (whey, soy, gluten)
Number of subjects: 72

Group type: EXPERIMENTAL
Intervention: Fasting GLP-1 concentrations
Number of subjects: 72

Group type: EXPERIMENTAL
Intervention: Postprandial GLP-1 responses
Number of subjects: 72
Study: 15331551

Group type: EXPERIMENTAL
Intervention: Intravenous exenatide (0.066 pmol.kg(‐1).min(‐1))
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study: 11359035

Group type: EXPERIMENTAL
Intervention: Phalangeal amplitude‐dependent speed of sound (Ad‐SOS) measurement
Number of subjects: 228

Group type: EXPERIMENTAL
Intervention: Partial correlations adjusted for important confounding variables
Number of subjects: 228
Study: 9156366

Group type: EXPERIMENTAL
Intervention: Substance P (30 and 90 ng/min for 2 min)
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Intracoronary acetylcholine (10 micrograms/min for 2 min)
Number of subjects: 8

Group type: COMPARATOR
Intervention: NG‐monomethyl‐L‐arginine (L‐NMMA) at 200 mumol
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Acetylcholine (4, 8, and 16 micrograms/min for 2 min)
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Substance P (0.8, 1.6, and 3.2 ng/min for 2 min)
Number of subjects: 8

Group type: COMPARATOR
Intervention: Intraarterial L‐NMMA (8 mumol/min for 5 min)
Number of subjects: 8
Study: 8333471

Group type: EXPERIMENTAL
Intervention: Leuprolide acetate depot (3.75 mg injected monthly)
Number of subjects: 270

Group type: EXPERIMENTAL
Intervention: Danazol (800 mg administered orally daily)
Number of subjects: 270
Study: 2436919

Group type: EXPERIMENTAL
Intervention: Trimoprostil (prostaglandin E2 analogue)
Number of subjects: 0
Study: 29965967

Group type: EXPERIMENTAL
Intervention: MJ8VAX (50 μg of peptide conjugate J8-DT)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: MJ8VAX
Number of subjects: 10

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study: 27100427

Group type: EXPERIMENTAL
Intervention: Dinner-to-bed time <3 hours
Number of subjects: 917

Group type: EXPERIMENTAL
Intervention: Post-dinner nonwalk
Number of subjects: 917

Group type: EXPERIMENTAL
Intervention: Dinner-to-bed time <3 hours and post-dinner nonwalk
Number of subjects: 917

Group type: EXPERIMENTAL
Intervention: Interaction of dinner-to-bed time and post-dinner walk
Number of subjects: 917
Study: 25448661

Group type: EXPERIMENTAL
Intervention: Lightweight mesh (LW)
Number of subjects: 226

Group type: COMPARATOR
Intervention: Heavyweight mesh (HW)
Number of subjects: 226
Study: 22225699

Group type: EXPERIMENTAL
Intervention: Provider training with rapid diagnostic tests (RDTs)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Enhanced provider training with rapid diagnostic tests (RDTs)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Current practice without RDTs
Number of subjects: 0
Study: 19160429

Group type: EXPERIMENTAL
Intervention: Tamoxifen 20 mg/d for 6 months
Number of subjects: 25

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 25
Study: 17469668

Group type: EXPERIMENTAL
Intervention: 100% effort
Number of subjects: 49

Group type: COMPARATOR
Intervention: 50% effort
Number of subjects: 49
Study: 15670299

Group type: EXPERIMENTAL
Intervention: Endocervical brush first (564 cases)
Number of subjects: 1129

Group type: COMPARATOR
Intervention: Spatula first (565 cases)
Number of subjects: 1129

Group type: EXPERIMENTAL
Intervention: Both methods
Number of subjects: 1129
Study: 12105320

Group type: EXPERIMENTAL
Intervention: Donepezil (5 mg/d for 30 days)
Number of subjects: 18

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 18
Study: 10199318

Group type: EXPERIMENTAL
Intervention: Supplemented enteral formula (enriched with arginine, RNA, and omega-3 fatty acids)
Number of subjects: 206

Group type: COMPARATOR
Intervention: Control enteral formula
Number of subjects: 206
Study: 8789587

Group type: EXPERIMENTAL
Intervention: 6 days/week training during TP1
Number of subjects: 19

Group type: COMPARATOR
Intervention: 3 alternate days/week training during TP2
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: Baseline training (S1 and S2)
Number of subjects: 19
Study: 1968320

Group type: EXPERIMENTAL
Intervention: Isoflurane (1.2%)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Halothane (0.7%)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Alfentanil-N2O
Number of subjects: 60
Study: 6457060

Group type: EXPERIMENTAL
Intervention: 400 mg/d disodium dichloromethylene diphosphonate (Cl2MDP)
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: 1,600 mg/d disodium dichloromethylene diphosphonate (Cl2MDP)
Number of subjects: 21

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 21
Study: 31610101

Group type: EXPERIMENTAL
Intervention: BHV-0223 (40 mg)
Number of subjects: 133

Group type: EXPERIMENTAL
Intervention: BHV-0223 (40 mg) under fed conditions
Number of subjects: 133

Group type: COMPARATOR
Intervention: Oral riluzole tablets (50 mg)
Number of subjects: 133
Study: 31000063

Group type: EXPERIMENTAL
Intervention: Mechanochemical Ablation (MOCA)
Number of subjects: 213

Group type: COMPARATOR
Intervention: Radiofrequency Ablation (RFA)
Number of subjects: 213
Study: 27377301

Group type: EXPERIMENTAL
Intervention: sirolimus- and probucol-eluting stents
Number of subjects: 311

Group type: COMPARATOR
Intervention: zotarolimus-eluting stents
Number of subjects: 311
Study: 27880997

Group type: EXPERIMENTAL
Intervention: TDF+NA
Number of subjects: 32

Group type: COMPARATOR
Intervention: ADV+NA
Number of subjects: 32
Study: 24291054

Group type: EXPERIMENTAL
Intervention: 500 mg P. emblica extract
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: 75 mg clopidogrel
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: 75 mg ecosprin
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: 500 mg P. emblica + 75 mg clopidogrel
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: 500 mg P. emblica + 75 mg ecosprin
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: 500 mg P. emblica extract (twice daily)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: 75 mg clopidogrel (once daily)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: 75 mg ecosprin (once daily)
Number of subjects: 10
Study: 22307069

Group type: EXPERIMENTAL
Intervention: Intensive lifestyle intervention (ILI)
Number of subjects: 3903

Group type: EXPERIMENTAL
Intervention: Highest genetic risk score (GRS)
Number of subjects: 3903

Group type: COMPARATOR
Intervention: Control condition
Number of subjects: 3903
Study: 19755613

Group type: EXPERIMENTAL
Intervention: Tadalafil 20 mg daily for 4 weeks
Number of subjects: 39

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 39
Study: 17218575

Group type: EXPERIMENTAL
Intervention: Hypercapnia (5% carbon dioxide)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Hyperoxia (40% oxygen)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Control (room air)
Number of subjects: 30
Study: 15376812

Group type: EXPERIMENTAL
Intervention: Critical word length measured relative to the length of other words in the list
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Recognition experiments with words of lengths that never occurred in a studied list
Number of subjects: 0
Study: 11600564

Group type: EXPERIMENTAL
Intervention: Simvastatin treatment in subjects with null mutations
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: Simvastatin treatment in subjects with defective mutations
Number of subjects: 42
Study: 9637897

Group type: EXPERIMENTAL
Intervention: Amoxicillin (40 mg/kg/day)
Number of subjects: 113

Group type: COMPARATOR
Intervention: Penicillin V (lower dosage)
Number of subjects: 113
Study: 8089542

Group type: EXPERIMENTAL
Intervention: EMLA cream 5%
Number of subjects: 47

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 47
Study: 2683937

Group type: EXPERIMENTAL
Intervention: 20 microL of levobunolol
Number of subjects: 117

Group type: EXPERIMENTAL
Intervention: 35 microL of levobunolol
Number of subjects: 117

Group type: EXPERIMENTAL
Intervention: 50 microL of levobunolol
Number of subjects: 117

Group type: COMPARATOR
Intervention: 35 microL of vehicle (control)
Number of subjects: 117
Study: 1097869

Group type: EXPERIMENTAL
Intervention: Maprotiline (Ludiomil)
Number of subjects: 71

Group type: COMPARATOR
Intervention: Imipramine
Number of subjects: 71
Study: 31956917

Group type: EXPERIMENTAL
Intervention: Higher burden of baseline white matter hyperintensity (WMH)
Number of subjects: 388

Group type: COMPARATOR
Intervention: Baseline infarcts
Number of subjects: 388

Group type: COMPARATOR
Intervention: Baseline microbleeds
Number of subjects: 388
Study: 31013190

Group type: EXPERIMENTAL
Intervention: 6-week scapular stabilization exercises with abdominal control feedback (n = 45)
Number of subjects: 135

Group type: EXPERIMENTAL
Intervention: 6-week scapular stabilization exercises without abdominal control feedback (n = 45)
Number of subjects: 135

Group type: COMPARATOR
Intervention: Active self-exercise (Control group, n = 45)
Number of subjects: 135
Study: 28492789

Group type: EXPERIMENTAL
Intervention: Long-acting lignocaine-based blood cardioplegia (single dose)
Number of subjects: 110

Group type: COMPARATOR
Intervention: Short-acting St Thomas 1 blood cardioplegia (repeated every 20 minutes)
Number of subjects: 110
Study: 25922328

Group type: EXPERIMENTAL
Intervention: Supervised use of facemasks for 7 days
Number of subjects: 0

Group type: COMPARATOR
Intervention: Standard measures
Number of subjects: 0
Study: 22836603

Group type: EXPERIMENTAL
Intervention: Reebok Core Board (RCB) during deep squat task
Number of subjects: 13

Group type: COMPARATOR
Intervention: Ground during deep squat task
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: Increasing weight loads (body weight, 30%RM, 60%RM)
Number of subjects: 13
Study: 21913385

Group type: EXPERIMENTAL
Intervention: Ultrasound cavitation therapy (USC) using Sonoca‐180 unit
Number of subjects: 231

Group type: COMPARATOR
Intervention: Basic therapy (control group)
Number of subjects: 231
Study: 18642029

Group type: EXPERIMENTAL
Intervention: Octreotide 30 mg im on day 1
Number of subjects: 38

Group type: EXPERIMENTAL
Intervention: Octreotide 30 mg on day 1 plus Imatinib 400 mg po daily
Number of subjects: 38

Group type: EXPERIMENTAL
Intervention: Oxaliplatin on day 1 (60 mg-90 mg/m2)
Number of subjects: 38

Group type: EXPERIMENTAL
Intervention: Oxaliplatin on day 1, 8, 15 (20 mg-30 mg/m2) plus octreotide 30 mg on day 1 plus imatinib 400 mg po daily
Number of subjects: 38
Study: 16686913

Group type: EXPERIMENTAL
Intervention: Post-methionine load homocysteine values
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Folate levels
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: MTHFR C677T and A1298C polymorphisms
Number of subjects: 45
Study: 15633480

Group type: EXPERIMENTAL
Intervention: Sentinel lymph node biopsy (SLNB) using subdermal or peritumoral injection of vital blue dye and/or both substances together.
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Sentinel lymph node biopsy (SLNB)
Number of subjects: 0
Study: 11425807

Group type: EXPERIMENTAL
Intervention: Rofecoxib (25 mg, orally, once daily for 9 consecutive days)
Number of subjects: 13

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: Rofecoxib and Placebo
Number of subjects: 13
Study: 9230720

Group type: EXPERIMENTAL
Intervention: Salbutamol (300 micrograms)
Number of subjects: 8

Group type: COMPARATOR
Intervention: Ipratropium bromide (80 micrograms)
Number of subjects: 8
Study: 8574511

Group type: EXPERIMENTAL
Intervention: midazolam 100 micrograms/kg by jet‐injection (JI)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: midazolam 150 micrograms/kg by jet‐injection (JI)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: midazolam 200 micrograms/kg by jet‐injection (JI)
Number of subjects: 40

Group type: COMPARATOR
Intervention: midazolam 80 micrograms/kg i.m by conventional syringe‐needle
Number of subjects: 40
Study: 2203257

Group type: EXPERIMENTAL
Intervention: Vitamin E (800 mg dl-alpha-tocopheryl acetate)
Number of subjects: 32
Study: 393520

Group type: EXPERIMENTAL
Intervention: Sustained release propranolol capsules 160 mg once daily
Number of subjects: 8

Group type: COMPARATOR
Intervention: Standard propranolol tablets 40 mg four times daily
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Both formulations
Number of subjects: 8
Study: 30951620

Group type: EXPERIMENTAL
Intervention: Rotary system (PROTAPER NEXT® ‐ PTN)
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Reciprocating system (WaveOne® ‐ WO)
Number of subjects: 48

Group type: COMPARATOR
Intervention: Hand K‐files
Number of subjects: 48
Study: 28857007

Group type: EXPERIMENTAL
Intervention: Community Flexible Integrated Responsive Support Team
Number of subjects: 113

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 113
Study: 28500900

Group type: EXPERIMENTAL
Intervention: Autologous mesenchymal stem cells (MSC) therapy with a target dose of 1×10^6 cells/kg intravenously and 0.1×10^6 cells/kg intrathecally
Number of subjects: 22

Group type: COMPARATOR
Intervention: Standard treatment with anti-epileptic drugs (AED)
Number of subjects: 22